| Financial Year |
March 31 2023 |
| Monetary Funds |
14,565,506,161.95 |
| Held-for-trading Financial Assets |
77,147.04 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,752,770,468.58 |
| Advances to Suppliers |
20,786,446.32 |
| Other Receivables |
71,677,962.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
22,635,418.46 |
| Dividend Receivable |
12,300,000.00 |
| Inventories |
46,456,703.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,798,752.55 |
| Total Current Assets |
17,462,073,643.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,559,536,141.16 |
| Investment Properties |
-- |
| Fixed Assetes |
24,261,286,704.37 |
| Under-construction Projects |
2,257,190,642.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
435,703,616.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
153,623,320.14 |
| Deferred Income Tax Assets |
2,159,419,486.67 |
| Other Non-Current Assets |
18,247,027.83 |
| Sub-Total of Non-Current Assets |
53,037,879,610.21 |
| Total Assets |
70,499,953,253.33 |
| Short-Term Loans |
1,449,747,422.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,108,378,080.54 |
| Accounts Received In Advance |
202,830,599.50 |
| Employee Compensation Payable |
745,889,923.76 |
| Taxes Payable |
130,972,506.43 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,233,596,514.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,433,428,831.09 |
| Other Current Liabilities |
4,015,898,377.96 |
| Sub-Total of Current Liabilities |
11,390,858,994.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
18,088,960,290.24 |
| Total Liabilities |
29,479,819,284.34 |
| Paid-In Capital(Or Share Stock) |
2,488,481,340.00 |
| Capital Surplus |
16,503,934,089.70 |
| Surplus Reserve |
1,504,004,168.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
19,011,833,979.41 |
| Minority Stockholder's Interest |
1,511,880,391.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
39,508,253,577.11 |
| Owner's Equity（Stockholder's Equity） |
41,020,133,968.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
70,499,953,253.33 |
